185 related articles for article (PubMed ID: 36434610)
1. Correlations between serum levels of microRNA-148a-3p and microRNA-485-5p and the progression and recurrence of prostate cancer.
He W; Zhang F; Jiang F; Liu H; Wang G
BMC Urol; 2022 Nov; 22(1):195. PubMed ID: 36434610
[TBL] [Abstract][Full Text] [Related]
2. Biomarker Potential of Plasma MicroRNA-150-5p in Prostate Cancer.
Paunescu IA; Bardan R; Marcu A; Nitusca D; Dema A; Negru S; Balacescu O; Balacescu L; Cumpanas A; Sirbu IO; Petrut B; Seclaman E; Marian C
Medicina (Kaunas); 2019 Sep; 55(9):. PubMed ID: 31484346
[No Abstract] [Full Text] [Related]
3. Evaluation of Serum MicroRNAs (miR-9-5p, miR-17-5p, and miR-148a-3p) as Potential Biomarkers of Breast Cancer.
Li X; Tang X; Li K; Lu L
Biomed Res Int; 2022; 2022():9961412. PubMed ID: 35111850
[TBL] [Abstract][Full Text] [Related]
4. Serum Levels of miR-223-3p and miR-223-5p in Prostate Diseases.
Dülgeroğlu Y; Eroğlu O
Microrna; 2020; 9(4):303-309. PubMed ID: 33155933
[TBL] [Abstract][Full Text] [Related]
5. miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer.
Ghorbanmehr N; Gharbi S; Korsching E; Tavallaei M; Einollahi B; Mowla SJ
Prostate; 2019 Jan; 79(1):88-95. PubMed ID: 30194772
[TBL] [Abstract][Full Text] [Related]
6. Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role.
Cochetti G; Poli G; Guelfi G; Boni A; Egidi MG; Mearini E
Onco Targets Ther; 2016; 9():7545-7553. PubMed ID: 28008272
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of epi-miRNA expression levels in local/locally advanced and metastatic prostate cancer patients.
Gurbuz V; Kiliccioglu I; Dikmen AU; Bilen CY; Sozen S; Konac E
Gene; 2020 Oct; 758():144963. PubMed ID: 32683077
[TBL] [Abstract][Full Text] [Related]
8. Human Papillomavirus 16 Oncoproteins Downregulate the Expression of miR-148a-3p, miR-190a-5p, and miR-199b-5p in Cervical Cancer.
Han MS; Lee JM; Kim SN; Kim JH; Kim HS
Biomed Res Int; 2018; 2018():1942867. PubMed ID: 30627542
[TBL] [Abstract][Full Text] [Related]
9. MiR-182-5p and miR-375-3p Have Higher Performance Than PSA in Discriminating Prostate Cancer from Benign Prostate Hyperplasia.
Abramovic I; Vrhovec B; Skara L; Vrtaric A; Nikolac Gabaj N; Kulis T; Stimac G; Ljiljak D; Ruzic B; Kastelan Z; Kruslin B; Bulic-Jakus F; Ulamec M; Katusic-Bojanac A; Sincic N
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33922968
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs as biomarkers for prostate cancer prognosis: a systematic review and a systematic reanalysis of public data.
Rana S; Valbuena GN; Curry E; Bevan CL; Keun HC
Br J Cancer; 2022 Feb; 126(3):502-513. PubMed ID: 35022525
[TBL] [Abstract][Full Text] [Related]
11. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
[TBL] [Abstract][Full Text] [Related]
12. Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer.
Zhang J; Zhang Y; Shen W; Fu R; Ding Z; Zhen Y; Wan Y
Biomed Pharmacother; 2019 Sep; 117():109058. PubMed ID: 31176168
[TBL] [Abstract][Full Text] [Related]
13. Potential miRNA biomarkers for the diagnosis and prognosis of esophageal cancer detected by a novel absolute quantitative RT-qPCR method.
Lin Z; Chen Y; Lin Y; Lin H; Li H; Su X; Fang Z; Wang J; Wei Q; Teng J; Zhang Z
Sci Rep; 2020 Nov; 10(1):20065. PubMed ID: 33208781
[TBL] [Abstract][Full Text] [Related]
14. miR-96-5p, miR-134-5p, miR-181b-5p and miR-200b-3p heterogenous expression in sites of prostate cancer versus benign prostate hyperplasia-archival samples study.
Pełka K; Klicka K; Grzywa TM; Gondek A; Marczewska JM; Garbicz F; Szczepaniak K; Paskal W; Włodarski PK
Histochem Cell Biol; 2021 Mar; 155(3):423-433. PubMed ID: 33331954
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Value of Exosomal miR-148a-3p in the Serum of Patients with Differentiated Thyroid Cancer.
Li S; Zhang S; Yang W; Li F; Long H
Clin Lab; 2021 Feb; 67(2):. PubMed ID: 33616326
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of serum miR-148a-3p are associated with prostate cancer.
Dybos SA; Flatberg A; Halgunset J; Viset T; Rolfseng T; Kvam S; Skogseth H
APMIS; 2018 Sep; 126(9):722-731. PubMed ID: 30160020
[TBL] [Abstract][Full Text] [Related]
17. Co-expression profiling of plasma miRNAs and long noncoding RNAs in gastric cancer patients.
Ghaedi H; Mozaffari MAN; Salehi Z; Ghasemi H; Zadian SS; Alipoor S; Hadianpour S; Alipoor B
Gene; 2019 Mar; 687():135-142. PubMed ID: 30447342
[TBL] [Abstract][Full Text] [Related]
18. MiR-148a the epigenetic regulator of bone homeostasis is increased in plasma of osteoporotic postmenopausal women.
Bedene A; Mencej Bedrač S; Ješe L; Marc J; Vrtačnik P; Preželj J; Kocjan T; Kranjc T; Ostanek B
Wien Klin Wochenschr; 2016 Dec; 128(Suppl 7):519-526. PubMed ID: 27900532
[TBL] [Abstract][Full Text] [Related]
19. Expression of miR-490-5p, miR-148a-3p and miR-608 in bladder cancer and their effects on the biological characteristics of bladder cancer cells.
Xiang M; Yuan W; Zhang W; Huang J
Oncol Lett; 2019 May; 17(5):4437-4442. PubMed ID: 30988813
[TBL] [Abstract][Full Text] [Related]
20. Functional roles and potential clinical application of miRNA-345-5p in prostate cancer.
Tinay I; Tan M; Gui B; Werner L; Kibel AS; Jia L
Prostate; 2018 Sep; 78(12):927-937. PubMed ID: 29748958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]